Price Data Unavailable
ESSA is a clinical-stage pharmaceutical company focused on developing novel and proprietary therapies for the treatment of patients with prostate cancer.
Next stock EPSN
Previous stock EPAY
WallstreetBets Trending Stocks (24h)